Welcome : Guest

ReNeuron Group Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ReNeuron Group Plc, which is principally involved in Researching and Developing Therapies Using Stem Cells. Illustrated with 26 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-41812
Price: $1300
Company Type: Public
Pages: 28
Date: February 2016
Market Data Tables: 26

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Stem Cell Transplantation......2
Table 1: Stem Cell Transplantation Market by Category for American Indian and Alaskan Natives in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......2
Table 2: Stem Cell Transplantation Market by Category for Asians in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......3
Table 3: Stem Cell Transplant Market by Category for Black and African Americans in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......4
Table 4: Stem Cell Transplantation Market by Category for Native Hawalian and Other Pacific Islanders in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......5
Table 5: Stem Cell Transplantation Market by Category for Whites in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......6
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)......7
Table 6: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......7
Table 7: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Bone Marrow Failure by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......8
Table 8: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......9
Table 9: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Leukemias by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......10
Table 10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......11
Table 11: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......12
Table 12: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......13
Table 13: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......14
Table 14: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Plasma Cell Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......15
Table 15: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......16
Table 16: Haematopoietic Stem Cell Transplantation (HSCT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union, United States and Rest Of World......17
Table 17: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Americas (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Chronic Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) and Others......18
Table 18: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......19
Table 19: Number of β-thalassemia Patients for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Category in Europe (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow (BM), Mixed Chimerism, Peripheral Blood (PB), Unrelated Cord Blood Transplantation (UCB) and Uterine Natural Killer (UNK)......20
Autologous Stem Cells......21
Table 20: Autologous Stem Cell Market by Disease Worldwide (2014) – Percentage Share Breakdown by Value for Infection, New Malignancy, Organ Failure, Primary Disease and Others......21
Bone Marrow Stromal Cells......22
Table 21: Bone Marrow Stromal Cells by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for CD34+ and CD31-, Ebdothelial Cells, Stem Cells, Tissue Macrophages, Vascular Smooth Muscle Cells, and White Blood Cells......22
Human Leukocyte Antigen - Identical Sibling Stem Cells......23
Table 22: Human Leukocyte Antigen (HLA) - Identical Sibling Stem Cell Market by Disease Worldwide (2014) - Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......23
Unrelated Donor Stem Cells......24
Table 23: Unrelated Donor Stem Cells Market by Disease Worldwide (2014) – Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......24
Transplants......25
Table 24: Transplant Market by Cell Source Worldwide (2014) - Percentage Share Breakdown by Value for Bone Marrow, Cord Blood and Peripheral Blood Stem Cell......25
Table 25: Adult Recipients (18+ years) Transplant Market by Cell Source in Japan (2014) - Percentage Share Breakdown by Volume for Bone Marrow, Cord Blood and Peripheral Blood Stem Cells......26
Table 26: Paediatric Recipients (<18 Years) Transplant Market by Cell Source in Japan (2014) - Percentage Share Breakdown by Volume for Bone Marrow, Cord Blood and Peripheral Blood Stem Cells......27